These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 18330505

  • 1. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.
    Perren A, Cerutti B, Lepori M, Senn V, Capelli B, Duchini F, Domenighetti G.
    Infection; 2008 Mar; 36(2):163-6. PubMed ID: 18330505
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
    Pizzini A, Lunger F, Sahanic A, Nemati N, Fuchs D, Weiss G, Kurz K, Bellmann-Weiler R.
    COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
    [Abstract] [Full Text] [Related]

  • 3. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
    Agnello L, Bellia C, Di Gangi M, Lo Sasso B, Calvaruso L, Bivona G, Scazzone C, Dones P, Ciaccio M.
    Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341
    [Abstract] [Full Text] [Related]

  • 4. Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ.
    Krüger S, Ewig S, Kunde J, Hartmann O, Marre R, Suttorp N, Welte T, CAPNETZ study group.
    Clin Chim Acta; 2010 Dec 14; 411(23-24):1929-34. PubMed ID: 20699094
    [Abstract] [Full Text] [Related]

  • 5. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM, Teixeira-Pinto A, Basílio C, Sousa-Dias C, Mergulhão P, Paiva JA.
    J Crit Care; 2013 Dec 14; 28(6):970-4. PubMed ID: 24216331
    [Abstract] [Full Text] [Related]

  • 6. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis.
    Niu WY, Wan YG, Li MY, Wu ZX, Zhang LG, Wang JX.
    Eur Rev Med Pharmacol Sci; 2013 Dec 14; 17(24):3329-33. PubMed ID: 24379064
    [Abstract] [Full Text] [Related]

  • 7. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia.
    Long W, Deng X, Zhang Y, Lu G, Xie J, Tang J.
    Respirology; 2011 Jul 14; 16(5):819-24. PubMed ID: 21507143
    [Abstract] [Full Text] [Related]

  • 8. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
    Lindstrom ST, Wong EK.
    Intern Med J; 2014 Apr 14; 44(4):390-7. PubMed ID: 24528892
    [Abstract] [Full Text] [Related]

  • 9. Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.
    Galetto-Lacour A, Alcoba G, Posfay-Barbe KM, Cevey-Macherel M, Gehri M, Ochs MM, Brookes RH, Siegrist CA, Gervaix A.
    Pediatr Infect Dis J; 2013 Nov 14; 32(11):1175-9. PubMed ID: 23694836
    [Abstract] [Full Text] [Related]

  • 10. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
    Daniels JM, Schoorl M, Snijders D, Knol DL, Lutter R, Jansen HM, Boersma WG.
    Chest; 2010 Nov 14; 138(5):1108-15. PubMed ID: 20576731
    [Abstract] [Full Text] [Related]

  • 11. [The value of serum procalcitonin in treatment of community acquired pneumonia in outpatient].
    Long W, Deng XQ, Tang JG, Xie J, Zhang YC, Zhang Y, Gao YY, Lu G.
    Zhonghua Nei Ke Za Zhi; 2009 Mar 14; 48(3):216-9. PubMed ID: 19576090
    [Abstract] [Full Text] [Related]

  • 12. The value of serum procalcitonin in differential diagnosis of pulmonary embolism and community-acquired pneumonia.
    Köktürk N, Kanbay A, Bukan N, Ekim N.
    Clin Appl Thromb Hemost; 2011 Oct 14; 17(5):519-25. PubMed ID: 20699253
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia.
    Lee JY, Hwang SJ, Shim JW, Jung HL, Park MS, Woo HY, Shim JY.
    Korean J Lab Med; 2010 Aug 14; 30(4):406-13. PubMed ID: 20805714
    [Abstract] [Full Text] [Related]

  • 14. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A, Christ-Crain M, Thomann R, Hoess C, Henzen C, Werner Z, Mueller B, Schuetz P, ProHOSP Study Group.
    Clin Chem Lab Med; 2015 Mar 14; 53(4):559-66. PubMed ID: 25014522
    [Abstract] [Full Text] [Related]

  • 15. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia.
    Esposito S, Tagliabue C, Picciolli I, Semino M, Sabatini C, Consolo S, Bosis S, Pinzani R, Principi N.
    Respir Med; 2011 Dec 14; 105(12):1939-45. PubMed ID: 21959024
    [Abstract] [Full Text] [Related]

  • 16. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
    Justo D, Lachmi S, Saar N, Joffe E, Atzmony L, Mashav N, Henis O, Sade B, Chundadze T, Steinvil A, Paran Y.
    Eur J Intern Med; 2009 Sep 14; 20(5):518-21. PubMed ID: 19712857
    [Abstract] [Full Text] [Related]

  • 17. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
    Bafadhel M, Clark TW, Reid C, Medina MJ, Batham S, Barer MR, Nicholson KG, Brightling CE.
    Chest; 2011 Jun 14; 139(6):1410-1418. PubMed ID: 21030489
    [Abstract] [Full Text] [Related]

  • 18. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.
    Claessens YE, Mathevon T, Kierzek G, Grabar S, Jegou D, Batard E, Loyer C, Davido A, Hausfater P, Robert H, Lavagna-Perez L, Bernot B, Plaisance P, Leroy C, Renaud B.
    Intensive Care Med; 2010 May 14; 36(5):799-809. PubMed ID: 20232049
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia.
    Horie M, Ugajin M, Suzuki M, Noguchi S, Tanaka W, Yoshihara H, Kawakami M, Kichikawa Y, Sakamoto Y.
    Am J Med Sci; 2012 Jan 14; 343(1):30-5. PubMed ID: 22207498
    [Abstract] [Full Text] [Related]

  • 20. Markers of treatment failure in hospitalised community acquired pneumonia.
    Menéndez R, Cavalcanti M, Reyes S, Mensa J, Martinez R, Marcos MA, Filella X, Niederman M, Torres A.
    Thorax; 2008 May 14; 63(5):447-52. PubMed ID: 18245147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.